Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:03 am Sale |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 3,413,552 9.900% |
-142,910 (-4.02%) |
Filing History |
| 2024-02-14 08:52 am Sale |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 1,793,966 5.220% |
-197,437 (-9.91%) |
Filing History |
| 2024-02-13 5:12 pm Purchase |
2023-12-29 | 13G | RAPT Therapeutics, Inc. RAPT |
The Vanguard Group | 2,056,221 5.980% |
2,056,221 (New Position) |
Filing History |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 3,843,387 11.173% |
-84,013 (-2.14%) |
Filing History |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
BlackRock Inc. BLK |
2,453,049 7.100% |
549,524 (+28.87%) |
Filing History |
| 2024-01-23 10:19 am Sale |
2023-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
STATE STREET CORP STT |
1,454,556 4.230% |
-486,167 (-25.05%) |
Filing History |
| 2023-10-23 4:40 pm Purchase |
2023-10-13 | 13G | RAPT Therapeutics, Inc. RAPT |
Deep Track Capital, LP | 1,991,403 5.800% |
1,991,403 (New Position) |
Filing History |
| 2023-06-12 2:10 pm Purchase |
2023-05-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 3,556,462 10.400% |
191,575 (+5.69%) |
Filing History |
| 2023-02-14 4:21 pm Purchase |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 3,679,838 9.900% |
480,475 (+15.02%) |
Filing History |
| 2023-02-14 2:31 pm Sale |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Perceptive Advisors LLC | 1,798,955 5.300% |
-1,128,610 (-38.55%) |
Filing History |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 3,364,887 9.900% |
-582,798 (-14.76%) |
Filing History |
| 2023-02-10 11:40 am Purchase |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
STATE STREET CORP STT |
1,940,723 5.720% |
1,940,723 (New Position) |
Filing History |
| 2023-02-10 09:08 am Purchase |
2023-02-09 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 3,927,400 11.571% |
975,186 (+33.03%) |
Filing History |
| 2023-02-09 12:31 pm Sale |
2023-02-09 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 2,952,214 8.698% |
-230,487 (-7.24%) |
Filing History |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
BlackRock Inc. BLK |
1,903,525 5.500% |
102,056 (+5.67%) |
Filing History |
| 2023-01-13 4:50 pm Purchase |
2022-05-10 | 13D | RAPT Therapeutics, Inc. RAPT |
The Column Group II, LP | 4,425,439 13.100% |
1,269,211 (+40.21%) |
Filing History |
| 2022-06-03 5:16 pm Purchase |
2022-05-24 | 13G | RAPT Therapeutics, Inc. RAPT |
Redmile Group LLC | 3,199,363 9.900% |
3,199,363 (New Position) |
Filing History |
| 2022-04-11 09:01 am Purchase |
2022-04-08 | 13G | RAPT Therapeutics, Inc. RAPT |
FMR LLC | 3,182,701 10.762% |
933,868 (+41.53%) |
Filing History |
| 2022-02-14 5:30 pm Purchase |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
Perceptive Advisors LLC | 2,927,565 9.900% |
1,350,084 (+85.58%) |
Filing History |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | RAPT Therapeutics, Inc. RAPT |
T. Rowe Price Associates, Inc. | 3,947,685 13.300% |
1,362,201 (+52.69%) |
Filing History |